AssistRx in Drug Channels — The Importance of Immediate Drug Price Transparency
03/05/2021
AssistRx
Chief Commercial Officer Edward Hensley recently contributed an article to Drug Channels to offer his insight on how accessing drug price transparency and affordability programs at the point of care can increase primary adherence and improve patient outcomes.
In the article, he examines the tools that grant healthcare providers access to prescription price transparency and allow them to electronically submit prior authorizations (PAs) in seconds from within their existing workflow. Using AssistRx’s Advanced Benefit Verification (ABV), real-time e-PA and other e-support services—integrated into iAssist, brand websites and CRMs—facilitates informed decisions, improved outcomes and optimal experiences.